1 year return (CAGR)
22.27%
Gracell Biotechnologies Inc. Exchange (NASDAQ, USD)
GRCL
575.00
-21.65 (-3.77%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
500.14%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
53.44B
Price/Sales
-
Ent value
52.03B
Price/Book
32.96
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 560.00 |
| Daily high | 575.00 |
| Daily low | 550.10 |
| Daily Volume | 4K |
| All-time high | 629.20 |
| 1y analyst estimate | 10.58 |
| Beta | -0.34 |
| EPS (TTM) | -5.67 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GRCL | S&P500 | |
| Current price drop from All-time high | -8.61% | -0.99% |
| Highest price drop | -95.26% | -56.47% |
| Date of highest drop | 25 Apr 2023 | 9 Mar 2009 |
| Avg drop from high | -53.08% | -10.68% |
| Avg time to new high | 24 days | 12 days |
| Max time to new high | 763 days | 1805 days |
News
No items found